Investment Thesis
Syra Health is unprofitable with negative operating cash flow and zero revenue growth, indicating a stagnant business model struggling to scale. While the company shows improving profitability trends (+76.2% YoY net income improvement) and maintains strong liquidity (4.06x current ratio) with no debt, the operational cash burn rate (~$448K annually) erodes the cash runway given the small revenue base of $7.2M.
Strengths
- Excellent liquidity position with 4.06x current and quick ratios, providing short-term financial stability
- Significant cash reserves of $1.6M representing 57% of total assets, providing runway for operational turnaround
- Zero long-term debt and low leverage (0.0x debt-to-equity), eliminating refinancing and bankruptcy risks
- Improving profitability trajectory with net income +76.2% YoY and EPS improving +84% YoY
Risks
- Company is operationally unprofitable with negative operating income (-$904.3K) and net margin of -12.4%
- Negative operating cash flow (-$447.7K) indicates cash burn despite positive cash balance, limiting sustainability
- Flat revenue growth (0.0% YoY) with only $7.2M in revenue demonstrates zero business expansion or market traction
- Negative returns on equity (-42.7%) and assets (-32.3%) showing capital is destroying rather than creating value
- Very small company with limited scale in competitive employment services sector, which typically operates on thin margins
- Minimal insider activity (1 Form 4 filing in 90 days) suggests lack of management confidence
Key Metrics to Watch
- Quarterly revenue growth trend - must achieve positive YoY growth to validate business model
- Operating cash flow - critical to watch if negative cash burn continues and remaining runway
- Path to operating profitability and EBITDA breakeven point
- Cash balance levels relative to quarterly burn rate
- Form 4 insider transactions - increased buying would signal management confidence in turnaround
Financial Metrics
Revenue
7.2M
Net Income
-896.3K
EPS (Diluted)
$-0.08
Free Cash Flow
-447.9K
Total Assets
2.8M
Cash
1.6M
Profitability Ratios
Gross Margin
34.4%
Operating Margin
-12.5%
Net Margin
-12.4%
ROE
-42.7%
ROA
-32.3%
FCF Margin
-6.2%
Balance Sheet & Liquidity
Current Ratio
4.06x
Quick Ratio
4.06x
Debt/Equity
0.00x
Debt/Assets
24.3%
Interest Coverage
-280.06x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-17T01:30:24.134531 |
Data as of: 2025-12-31 |
Powered by Claude AI